Overview
Flunarizine has remained the most prescribed therapy of episodic neurologic dysfunction in AHC for more than two decades. It is used to reduce the frequency and severity of AHC episodes. Published research supports flunarizine as a rational treatment for AHC. The decision to use flunarizine as a treatment for AHC should be considered under the direction and supervision of a person’s physician.
Known Side Effects of Flunarizine
Flunarizine is known to cause several common side effects and a few rare or more serious side effects. This is not specific to AHC use of Flunarizine, but to the medication itself.
Common Side Effects
- Drowsiness and fatigue are frequently reported and can affect up to 20% of patients.
- Weight gain and increased appetite are also common, affecting 10% of users.
- Upset stomach, nausea, heartburn, and dry mouth may occur as the body adjusts to the medication.
- Dizziness, weakness, and occasional headaches are also noted.
Rare and Serious Side Effects
- Depression or low mood is a significant concern, especially in patients with a history of depressive disorders.
- Extrapyramidal symptoms (such as tremor, muscle rigidity, or abnormal movements) have been observed, particularly in elderly patients or those predisposed to movement disorders.
Precautions
- Flunarizine should generally be avoided in people with Parkinson’s disease, movement disorders, or a history of depression.
- Allergic reactions such as skin rash, swelling of the face, difficulty breathing, or severe itching require urgent medical attention.
- Alcohol can enhance sedative effects and should be avoided while taking Flunarizine. Other less frequent issues include insomnia, visual disturbances, menstrual problems, breast pain, sexual dysfunction, and constipation.
If you experience severe symptoms or allergic reactions, medical advice should be sought immediately. Always discuss your medical history and other medications with your healthcare provider before starting Flunarizine.
https://www.medicinenet.com/flunarizine-oral_capsule_tablet/article.htm